𝔖 Bobbio Scriptorium
✦   LIBER   ✦

HIV integrase as a target for antiviral chemotherapy

✍ Scribed by Vasu Nair

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
383 KB
Volume
12
Category
Article
ISSN
1052-9276

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

One of the three key enzymes encoded by the pol gene of HIV is a M~r~ 32 000 protein called HIV integrase. This viral enzyme is involved in the integration of HIV DNA into host chromosomal DNA. There appears to be no functional equivalent of the enzyme in human cells. The biochemical mechanism of integration of HIV DNA into the host cell genome involves a carefully defined sequence of DNA tailoring (3′‐processing) and coupling (joining or integration) reactions. In spite of some effort in this area targeted at the discovery of therapeutically useful inhibitors of this viral enzyme, there are no drugs for HIV/AIDS in clinical use where the mechanism of action is inhibition of HIV integrase. Thus, new knowledge on inhibitors of this enzyme is of critical importance in the anti‐HIV drug discovery area. The focus of this review will be on several classes of compounds, including nucleotides, dinucleotides, oligonucleotides and miscellaneous small molecules such as heterocyclic systems, natural products, diketo acids and sulfones, that have been discovered as inhibitors of HIV integrase. Special emphasis in the review will be placed on discoveries from my laboratory on HIV integrase inhibitors that are non‐natural, nuclease‐resistant dinucleotides. Comments on future directions and the prospects for developing integrase inhibitors as therapeutic antiviral agents are discussed. Copyright © 2002 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

HIV integrase: a target for drug discove
HIV integrase: a target for drug discovery
✍ Ramon Puras Lutzke; Ronald Plasterk 📂 Article 📅 1997 🏛 Blackwell Publishing 🌐 English ⚖ 536 KB

Current antiviral strategies against HIV rely on structure–function analysis of HIV reverse transcriptase (RT) and protease (PR). The third viral __pol__ gene product, HIV integrase (IN), is also a good target for drug discovery, since IN is essential for retroviral replication and, moreover, it has

Human cytomegalovirus terminase as a tar
Human cytomegalovirus terminase as a target for antiviral chemotherapy
✍ Elke Bogner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

## Abstract Herpesviral DNA packaging is a complex process involving binding and cleavage of DNA containing the specific DNA‐packaging motifs, __pac1__ and __pac2__, and packaging of the resulting unit‒length genomes into preformed procapsids. This process is believed to be mediated by two packagin

Protein–protein interactions as targets
Protein–protein interactions as targets for antiviral chemotherapy
✍ Arianna Loregian; Howard S. Marsden; Giorgio Palù 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB

## Abstract Most cellular and viral processes depend on the coordinated formation of protein–protein interactions. With a better understanding of the molecular biology and biochemistry of human viruses it has become possible to screen for and detect inhibitors with activity against specific viral f